Clinical Research Directory
Browse clinical research sites, groups, and studies.
Testing a Real-time Electronic Antiretroviral Adherence Monitoring Intervention
Sponsor: University of Illinois at Chicago
Summary
The investigators propose using an electronic adherence device that is basically a pill container that can alert when it is not opened at a scheduled time. The investigators will use this device to alert the medication user at the time when medication is supposed to be taken if the device did not get opened and a pre-identified social support person or case manager when 2 or 7 consecutive days of nonadherence are detected, respectively. The investigators call our approach "A-Team" (Antiretroviral Therapy Electronic Adherence Monitoring). The aims of this application are to determine the acceptability and feasibility of real-time adherence monitoring in support persons and case managers of African American Men who have sex with Men and to test this approach for these men in a 6-month randomized controlled trial among 54 of these men living with HIV and measure ART adherence and viral suppression (the primary outcome).
Official title: Pilot Trial of a Real-time Electronic Adherence Monitoring Intervention for Antiretroviral Therapy
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
126
Start Date
2024-10-01
Completion Date
2026-07
Last Updated
2024-11-21
Healthy Volunteers
Yes
Conditions
Interventions
A-TEAM
Participants randomized to the intervention arm will receive the proposed intervention, which involves an electronic adherence device called Wisepill and triaged text alerts to the user, the social support, and the case manager for same day, two day, and seven day device non-openings.
Locations (1)
University of Illinois Chicago
Chicago, Illinois, United States